Attached files
| file | filename |
|---|---|
| 10-K - AIM ImmunoTech Inc. | v216127_10k.htm |
| EX-32.1 - AIM ImmunoTech Inc. | v216127_ex32-1.htm |
| EX-32.2 - AIM ImmunoTech Inc. | v216127_ex32-2.htm |
| EX-31.1 - AIM ImmunoTech Inc. | v216127_ex31-1.htm |
| EX-31.2 - AIM ImmunoTech Inc. | v216127_ex31-2.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Hemispherx Biopharma, Inc.
Philadelphia, Pennsylvania
We consent to the incorporation by reference in Registration Statements (No.s 333-160499, 333-57134, 118903 and 333-155528) on Form S-8 and Registration Statements (No.s 333-136187, 333-117178, 333-119017, 333-108645, 333-111135, 333-113796, 333-130008, 333-159856 and 333-151696) on Form S-3 of Hemispherx Biopharma, Inc. and Subsidiaries of our reports dated March 28, 2011 relating to our audit of the consolidated financial statements and the financial statement schedule, and internal control over financial reporting, which appear in this Annual Report on Form 10-K of Hemispherx Biopharma, Inc. for the year ended December 31, 2010.
|
/s/ McGladrey & Pullen LLP
|
|
McGladrey & Pullen LLP
|
|
Blue Bell, Pennsylvania
|
|
March 28, 2011
|